Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

16.17
Delayed Data
As of Dec 09
 +0.07 / +0.43%
Today’s Change
5.25
Today|||52-Week Range
18.24
+31.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash81.5M48.5M45.0M35.0M
 
 
 
 
 
Short Term Investment Cash51.4M-33.0M-2.5M-11.1M
 
 
 
 
 
Cash & Short Term Investments100.6M91.5M97.7M66.6M
 
 
 
 
 
 
ReceivablesReceivables0.00----0.00--
 
InventoriesInventories0.00----0.00--
 
Current AssetsOther Current Assets786.0K765.0K1.7M1.2M
 
 
 
 
 
Current Assets101.4M92.2M99.3M67.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross21.3M22.0M21.5M21.6M
 
 
 
 
 
Depreciation-20.1M-20.5M-20.5M-21.1M
 
 
 
 
 
Other Assets458.0K1.4M305.0K0.00
 
 
 
 
Total Assets103.0M95.2M100.7M68.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.7M6.6M3.1M0.00
 
 
 
 
Short Term Debt7.9M9.5M9.3M4.7M
 
 
 
 
 
Accrued Expenses6.6M13.0M14.6M8.8M
 
 
 
 
 
Other Current Liabilities6.6M13.0M14.6M10.1M
 
 
 
 
 
Other Liabilities23.5M32.2M30.9M17.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt4.5M13.9M4.7M0.00
 
 
 
 
Total Liabilities28.0M46.1M35.5M17.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity75.1M49.1M65.1M50.4M
 
 
 
 
 
Total Shareholder Equity75.1M49.1M65.1M50.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.0M2.4M3.1M3.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.